Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Multiple sclerosis or multiple possibilities: The continuing problem of misdiagnosis.
T-cell trafficking in the central nervous system.
[Recurring neuromyelitis without optic neuritis: a case report].
Detection of multiple sclerosis from exhaled breath using bilayers of polycyclic aromatic hydrocarbons and single-wall carbon nanotubes.
Interferon Beta and Glatiramer Acetate Therapy.
Neuromyelitis optica in patients with coexisting human immunodeficiency virus infections.
The Impact of a Patient Support Program for Multiple Sclerosis on Patient Satisfaction and Subjective Health Status.
Cognitive reserve and symptom experience in multiple sclerosis: A buffer to disability progression over time?
Multiple sclerosis: basic knowledge and new insights in perioperative management.
Disruption of melatonin circadian rhythm production is related to multiple sclerosis severity: A preliminary study.
Elevated concentration of C-reactive protein is associated with pregnancy-related co-morbidities but not with relapse activity in multiple sclerosis.
[Current immunotherapy of multiple sclerosis].
Exacerbation of experimental autoimmune encephalomyelitis after withdrawal of phenytoin and carbamazepine.
Tumor necrosis factor-alfa and interleukin-4 in cerbrospinal fluid and plasma in different clinical forms of multiple sclerosis.
Multiple Sclerosis and Amyotrophic Lateral Sclerosis: Finding and then Losing an Association.
Association of STAT4 rs7574865 polymorphism with autoimmune diseases: a meta-analysis.
C-ANCA positive necrotising scleritis and multiple sclerosis compatible with ocular Wegener: treatment with rituximab.
Hyperconnectivity is a Fundamental Response to Neurological Disruption.
Origin and evolution of deep brain stimulation.
[2011: What's new in dysimmune neuropathies.]
Occupational Exposure and Risk of Central Nervous System Demyelination.
Association of multiple sclerosis with restless legs syndrome and other sleep disorders in women.
In Vitro and In Vivo Models of Multiple Sclerosis.
Cost-Effectiveness of Disease-Modifying Therapies in Multiple Sclerosis.
Low dose zymosan ameliorates both chronic and relapsing experimental autoimmune encephalomyelitis.

Pages